However, augmentation of sCTLA-4 activity is expected to be a major mechanism for RGMB to suppress anti-tumor immunity, as it was shown that the negative correlation between RGMB expression and CTL activity in tumor tissues was more evident with higher levels of sCTLA-4. This evidence concerns the gene RGMB and neoplasm.